LONDON (AFX) - AIM-listed Provexis said it has entered into an exclusive
12-month agreement with an unnamed, global branded food group to jointly develop
and use Provexis' Fruitflow bioactive food ingredient, which has been shown to
combat thrombosis.
The company, which develops scientifically-proven functional and medical
foods, said the agreement will see the two groups jointly developing a
second-generation concentrated format of Fruitflow to increase the scope of its
applications.
Provexis described the agreement as "an important milestone" and noted it
hopes to establish a "long-term, global licensing deal" with the partner food
group within 12 months.
Meanwhile, Provexis also announced the resignation, with immediate effect,
of chief executive Stephen Franklin.
Stephen Moon, up until now the company's commercial director, has been
appointed as Franklin's replacement.
Franklin will continue to work at Provexis as acting director of research
until early 2007, the company said.
newsdesk@afxnews.com
Is this partner PEPSI ? cos this news was out 20 days back, if it is refering to PEPSICO then we are looking at 10P or higher soon.
http://www.advfn.com/news_Provexis_16228014.html